Dr. Reddy’s expands portfolio in Russia & CIS through in-licensing deals

[Original link] [DRL press release]

Dr Reddy’s Laboratories (DRL) today said it has entered into an agreement with drug major Cipla and UK-based Vitabiotics to market over-the-counter (OTC) and prescription drugs, besides nutraceutical products, in Russia and CIS countries.

As per the agreement with Cipla, Dr Reddy’s Laboratories has initiated sales and promotion of a select portfolio of OTC and prescription products in select therapy areas in Russia from the second quarter, the company said in a statement.

The launch of operations in Ukraine will take place in the next calender year, it added.

The company’s agreement with Vitabiotics is for a range of nutraceutical products for Russia and select CIS countries. The agreement provides Dr Reddy’s with exclusive marketing rights to two of Vitabiotics leading products, Jointace and Dietrim, it said.

The UK-based firm will supply these products on a long- term basis from its facilities in Europe, it added.

“The agreements give us access to a good number of products and OTC brands with existing sales that would immediately add to our revenues from the Russian and CIS market,” Dr Reddy’s MD and COO Satish Reddy said.

He further added: “We see long-term synergies, as Dr Reddy’s has a strong sales and marketing network and our partners have a basket of products already registered and distributed in these markets.”

DRL claimed it is the largest Indian pharmaceutical company in Russia. It entered the Russian market in 1992 and consolidated its position during the late 1990s.

“The agreement with Cipla will enhance Dr Reddy’s presence in the OTC space and in therapy areas of gastroenterology, dermatology and oncology in both Russia and Ukraine,” Dr Reddy’s Head of Russia & CIS Region M V Ramana said.


Jointace is combination of chondrotin, glucosamine and other nutrients

Dietrim is conjugated linoleic acid and other ingredients

About Guna

Interested to learn things around me
This entry was posted in Uncategorized. Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s